Significantly, in a mouse model of RCC-induced C3-induced lung metastasis, the inhibitors RS504393 and Navarixin, which target the CCL2/CCR2 or CXCL1/CXCR2 axis, respectively, successfully decreased metastasis. The gene discussed is CCR2; the disease is renal cell carcinoma.